Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention

Research output: Contribution to journalArticle

2 Citations (Scopus)
116 Downloads (Pure)

Abstract

About 30% of individuals with skin psoriasis will develop an inflammatory disease of the peripheral or axial skeleton involving synovial and/or entheseal tissue termed psoriatic arthritis (PsA). In most cases psoriasis will precede PsA by several years. Hence skin psoriasis provides an opportune model to investigate genetic and environmental factors that interact and contribute to the development of a common form of inflammatory arthritis. Further, the preexisting presence of psoriasis represents a unique opportunity for the early detection of arthritis and the potential for more effective intervention. However, despite the presence of psoriasis, there may be delay in the diagnosis of PsA that is associated with adverse longterm outcome. Undiagnosed disease is not uncommon, as demonstrated by studies applying screening questionnaires to primary care and dermatology clinic populations. Other potential risk factors, such as obesity and smoking, the presence of certain genetic and biomarker profiles, combined with accurate imaging modalities, offer the potential for more targeted screening. So in future it should be possible to detect PsA at a much earlier stage and prevent significant joint damage and associated disability before it happens.

Original languageEnglish
Pages (from-to)10-13
Number of pages4
JournalThe Journal of rheumatology. Supplement
Volume93
DOIs
Publication statusPublished - Nov 2015

Fingerprint

Psoriatic Arthritis
Psoriasis
Arthritis
Skin
Dermatology
Skeleton
Primary Health Care
Obesity
Joints
Biomarkers
Smoking
Population

Cite this

Verna Wright Lecture : Psoriatic Arthritis: The Need for Early Intervention. / McHugh, Neil J.

In: The Journal of rheumatology. Supplement, Vol. 93, 11.2015, p. 10-13.

Research output: Contribution to journalArticle

@article{b31ed57c8ded4749a5f0859db9fe88e8,
title = "Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention",
abstract = "About 30{\%} of individuals with skin psoriasis will develop an inflammatory disease of the peripheral or axial skeleton involving synovial and/or entheseal tissue termed psoriatic arthritis (PsA). In most cases psoriasis will precede PsA by several years. Hence skin psoriasis provides an opportune model to investigate genetic and environmental factors that interact and contribute to the development of a common form of inflammatory arthritis. Further, the preexisting presence of psoriasis represents a unique opportunity for the early detection of arthritis and the potential for more effective intervention. However, despite the presence of psoriasis, there may be delay in the diagnosis of PsA that is associated with adverse longterm outcome. Undiagnosed disease is not uncommon, as demonstrated by studies applying screening questionnaires to primary care and dermatology clinic populations. Other potential risk factors, such as obesity and smoking, the presence of certain genetic and biomarker profiles, combined with accurate imaging modalities, offer the potential for more targeted screening. So in future it should be possible to detect PsA at a much earlier stage and prevent significant joint damage and associated disability before it happens.",
author = "McHugh, {Neil J}",
year = "2015",
month = "11",
doi = "10.3899/jrheum.150625",
language = "English",
volume = "93",
pages = "10--13",
journal = "The Journal of rheumatology. Supplement",
issn = "0380-0903",
publisher = "Journal of Rheumatology",

}

TY - JOUR

T1 - Verna Wright Lecture

T2 - Psoriatic Arthritis: The Need for Early Intervention

AU - McHugh, Neil J

PY - 2015/11

Y1 - 2015/11

N2 - About 30% of individuals with skin psoriasis will develop an inflammatory disease of the peripheral or axial skeleton involving synovial and/or entheseal tissue termed psoriatic arthritis (PsA). In most cases psoriasis will precede PsA by several years. Hence skin psoriasis provides an opportune model to investigate genetic and environmental factors that interact and contribute to the development of a common form of inflammatory arthritis. Further, the preexisting presence of psoriasis represents a unique opportunity for the early detection of arthritis and the potential for more effective intervention. However, despite the presence of psoriasis, there may be delay in the diagnosis of PsA that is associated with adverse longterm outcome. Undiagnosed disease is not uncommon, as demonstrated by studies applying screening questionnaires to primary care and dermatology clinic populations. Other potential risk factors, such as obesity and smoking, the presence of certain genetic and biomarker profiles, combined with accurate imaging modalities, offer the potential for more targeted screening. So in future it should be possible to detect PsA at a much earlier stage and prevent significant joint damage and associated disability before it happens.

AB - About 30% of individuals with skin psoriasis will develop an inflammatory disease of the peripheral or axial skeleton involving synovial and/or entheseal tissue termed psoriatic arthritis (PsA). In most cases psoriasis will precede PsA by several years. Hence skin psoriasis provides an opportune model to investigate genetic and environmental factors that interact and contribute to the development of a common form of inflammatory arthritis. Further, the preexisting presence of psoriasis represents a unique opportunity for the early detection of arthritis and the potential for more effective intervention. However, despite the presence of psoriasis, there may be delay in the diagnosis of PsA that is associated with adverse longterm outcome. Undiagnosed disease is not uncommon, as demonstrated by studies applying screening questionnaires to primary care and dermatology clinic populations. Other potential risk factors, such as obesity and smoking, the presence of certain genetic and biomarker profiles, combined with accurate imaging modalities, offer the potential for more targeted screening. So in future it should be possible to detect PsA at a much earlier stage and prevent significant joint damage and associated disability before it happens.

UR - http://dx.doi.org/10.3899/jrheum.150625

U2 - 10.3899/jrheum.150625

DO - 10.3899/jrheum.150625

M3 - Article

C2 - 26523046

VL - 93

SP - 10

EP - 13

JO - The Journal of rheumatology. Supplement

JF - The Journal of rheumatology. Supplement

SN - 0380-0903

ER -